![CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Antibody - Culture Supernatant - Mouse Monoclonal Antibody [Clone Ber-H2 + CD30/412 ] IHC, IF, FC - Buy Now! |Abcepta CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Antibody - Culture Supernatant - Mouse Monoclonal Antibody [Clone Ber-H2 + CD30/412 ] IHC, IF, FC - Buy Now! |Abcepta](https://www.abcepta.com/assets/uploads/products/201512/AH12697_IHC_1.jpg)
CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) Antibody - Culture Supernatant - Mouse Monoclonal Antibody [Clone Ber-H2 + CD30/412 ] IHC, IF, FC - Buy Now! |Abcepta
![Panel of immunohistochemical markers confirming the coexpression of... | Download High-Resolution Scientific Diagram Panel of immunohistochemical markers confirming the coexpression of... | Download High-Resolution Scientific Diagram](https://www.researchgate.net/publication/308992916/figure/fig3/AS:416278268399618@1476259881453/Panel-of-immunohistochemical-markers-confirming-the-coexpression-of-CD30-and-CD15-in.png)
Panel of immunohistochemical markers confirming the coexpression of... | Download High-Resolution Scientific Diagram
![Low CD30 Expression in Non-Hodgkin's Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin – Consult QD Low CD30 Expression in Non-Hodgkin's Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin – Consult QD](https://consultqd.clevelandclinic.org/wp-content/uploads/sites/2/2019/05/650x450-CD3-40x.jpg)
Low CD30 Expression in Non-Hodgkin's Lymphoma Patients Does Not Predict Low Response to Brentuximab Vedotin – Consult QD
![CD30 Activates Both the Canonical and Alternative NF-κB Pathways in Anaplastic Large Cell Lymphoma Cells* - Journal of Biological Chemistry CD30 Activates Both the Canonical and Alternative NF-κB Pathways in Anaplastic Large Cell Lymphoma Cells* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a9e55310-7c86-449e-a091-1e624593cc39/gr1.jpg)
CD30 Activates Both the Canonical and Alternative NF-κB Pathways in Anaplastic Large Cell Lymphoma Cells* - Journal of Biological Chemistry
![Frontiers | Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma Frontiers | Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma](https://www.frontiersin.org/files/Articles/535614/fonc-10-00876-HTML/image_m/fonc-10-00876-g001.jpg)
Frontiers | Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma
![Frontiers | Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells Frontiers | Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells](https://www.frontiersin.org/files/Articles/446766/fonc-09-00945-HTML/image_m/fonc-09-00945-g001.jpg)
Frontiers | Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
![CD30 (Reed-Sternberg Cell Marker) Ab-4 Mouse Monoclonal Antibody, Epredia:Antibodies:Primary | Fisher Scientific CD30 (Reed-Sternberg Cell Marker) Ab-4 Mouse Monoclonal Antibody, Epredia:Antibodies:Primary | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/APD/product-images/F62868~p.eps-650.jpg)
CD30 (Reed-Sternberg Cell Marker) Ab-4 Mouse Monoclonal Antibody, Epredia:Antibodies:Primary | Fisher Scientific
CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Br
![A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb | Cancer Gene Therapy A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb | Cancer Gene Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41417-021-00295-8/MediaObjects/41417_2021_295_Fig1_HTML.png)
A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb | Cancer Gene Therapy
![Images from classic Hodgkin lymphoma, A. H&E, B. CD15, C. CD30, D. PAX5... | Download Scientific Diagram Images from classic Hodgkin lymphoma, A. H&E, B. CD15, C. CD30, D. PAX5... | Download Scientific Diagram](https://www.researchgate.net/publication/331007875/figure/fig1/AS:876672177942528@1586026343121/Images-from-classic-Hodgkin-lymphoma-A-H-E-B-CD15-C-CD30-D-PAX5-note-decreased_Q640.jpg)
Images from classic Hodgkin lymphoma, A. H&E, B. CD15, C. CD30, D. PAX5... | Download Scientific Diagram
![PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus | Modern Pathology PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2010.4/MediaObjects/41379_2010_Article_BFmodpathol20104_Fig1_HTML.jpg)
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus | Modern Pathology
![Colonic CD30 positive plasmablastic plasmacytoma masquerading as anaplastic large cell lymphoma - Pathology Colonic CD30 positive plasmablastic plasmacytoma masquerading as anaplastic large cell lymphoma - Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8938c8b2-4aa6-4043-89e0-8afaf2fe15d0/gr1_lrg.jpg)